| Company Name: |
Combio (Suzhou) Ltd. Gold |
| Tel: |
17751201929; 17751201929 |
| Email: |
jianyang_yu@combiosz.com |
|
| | H-Arg-Gly-Glu-Ser-OH Basic information |
| Product Name: | H-Arg-Gly-Glu-Ser-OH | | Synonyms: | R-G-E-S;rgespeptide;ARG-GLY-GLU-SER;RGES; R-G-E-S;[Glu3]-RGES,ControlforRGDPeptides;(4S)-4-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-5-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-5-oxopentanoic acid;L-Serine, L-arginylglycyl-L-α-glutamyl-;L-Arginylglycyl-L-α-glutamyl-L-serine | | CAS: | 93674-97-6 | | MF: | C16H29N7O8 | | MW: | 447.45 | | EINECS: | | | Product Categories: | Peptide | | Mol File: | 93674-97-6.mol |  |
| | H-Arg-Gly-Glu-Ser-OH Chemical Properties |
| density | 1.61±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | pka | 2.95±0.10(Predicted) | | Sequence | H-Arg-Gly-Glu-Ser-OH |
| | H-Arg-Gly-Glu-Ser-OH Usage And Synthesis |
| Uses | Arg-Gly-Glu-Ser is a polypeptide related to RGD and is a negative control for Arg-Gly-Asp-Ser (HY-12290)[1]. | | in vivo | Arg-Gly-Glu-Ser (5 mg/kg) in combination with LPS or saline + RGDS does not affect neutrophil and macrophage cell numbers and has no effect on protein accumulation compared with LPS- or saline-treated mice, respectively[1]. | | References | [1] Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10:18. DOI:10.1186/1465-9921-10-18 |
| | H-Arg-Gly-Glu-Ser-OH Preparation Products And Raw materials |
|